Medivolve announces the launch of an information campaign for investors and the resubmission of financial reports for the second quarter of 2022. – Bollyinside

0

TORONTO, August 24, 2022 (News) – Medivolve Inc. (“Medivolve” Where “Company”) (NEO: MEDV; OTC: COPRF; FRA: 4NC) is pleased to announce the launch of an investor marketing campaign to raise awareness of the Company within the investment community. The Company also announces that it has amended and resubmitted its interim condensed consolidated financial statements (“Financial data for the second quarter of 2022“) and appropriate management discussion and analysis (“Q2 2022 MDA“) For the six-month period ended June 30, 2022.

Wallstreet Investors Club

Medivolve has entered into a service agreement with Lion Capital Investment Limited (“Lion”) under which Lion will provide marketing services under the trade name Wallstreet Investor Club for a period of six months for the amount of $250,000. Lion is a marketing consultant based in the Cayman Islands. Lion has exclusive partnerships with Zemanta for content distribution and advertising platforms, giving Lion access to many other sites. Neither Lion nor any of its officers currently owns or intends to acquire, directly or indirectly, securities of the Company.

Reclassified Q2 2022 financial data and Q2 2022 management report.

The company has revised and resubmitted its Q2 2022 and Q2 2022 MD&A financials. The unaudited condensed interim consolidated financial statements for the three and six months ended June 30, 2022 and 2021, filed on SEDAR on August 15, 2022, have been revised to correct: the dates of the statement of cash flows which referred to wrong to the current and comparative periods presented as “December 31, 2022 and 2021” instead of “June 30, 2022 and 2021”; and the financial information presented in the statement of cash flows for the comparative period ended June 30, 2021, all of which were incorrect except for the net (loss) for the period. The MD&A for Q2 2022 has been updated to correct the commentary on the statement of cash flows, reflecting changes in the financial information for the comparative period 2021 presented in the updated financial data for Q2 2022 and an incorrect reference to “three months ended March 31”. , 2022”, which should refer to the “six months ended June 30, 2022”. The corrective disclosure was made at the request of the Ontario Securities Commission as part of the ongoing review of disclosures.

About Medivolve

Medivolve (NEO: MEDV; OTC: COPRF; FRA: 4NC) is a health technology company that seeks to rediscover the American healthcare system by leveraging a bespoke telehealth platform, clinical diagnostics network and a data-driven AI framework to improve patient care.

The company was born out of a health crisis; rethink, relearn and eventually reinvent a better functioning health system. Our network of retail collection points plays an important role in restoring health, enabling Americans to access fast, accurate and affordable clinical services when and where they need them. These centers will also play a key role in diagnostic testing, vaccination and other point-of-care services. We create breakthrough technologies to identify, treat and prevent medical conditions easier and faster. In doing so, we strive to provide patients with a holistic and empowered view of their personal health.

Our long-term mission is to solve systemic problems in a fragmented, overly complex and costly healthcare system. The next phase of Medivolve’s development is to change the model and combine the elements to build a profitable medical technology company. We are developing a unique and streamlined technology network to provide data-driven medical consultation, clinical diagnosis and prescription services. Our team shares a powerful purpose: to harness the transformative power of technology to create healthier lives.

Based on a specially designed platform based on artificial intelligence, we are developing a system that constantly becomes smarter, takes the guesswork out of diagnoses and flags critical health issues to help doctors, providing a high level of customization for each patient.

Please send your investment requests to: David Preiner, [email protected], 702-990-3737.

Forward-Looking Information Notice

This press release contains “forward-looking information” under applicable Canadian securities laws. Forward-looking information includes, but is not limited to, statements regarding Lion’s involvement in investor relations services, the implementation and functionality of the company’s telehealth platform, and the ability of the company to incorporate a Marbella pharmacy into its operations and expand its testing services beyond COVID-19[Generallyinformationaboutthefuturecanbeidentifiedusingforward-lookingterminologysuchas”plans””expected”or”unexpected””isexpected””budget””expected””estimates””forecasts””intends””predicts”or”does”not”anticipate”or”believe”orvariationsofthesewordsandphrasesorstatesthatcertainactionseventsorresults”may””could””or”will””will””occur”or”will”‘Theforward-lookinginformationissubjecttoknownandunknownrisksuncertaintiesandotherfactorsthatcouldcausetheactualresultsthelevelofactivitytheperformanceorachievementsoftheCompanyétéselonlecasdiffèrentsensiblementdeceuxexprimésousous-entendusparcesinformationsinformationsprospectivesycomprismaissanss’ylimiter:lesincertitudesliéesàlademanded’uneplateformedetélésantéetdeservicespharmaceutiques;lesfluxdetrésoreried’exploitationpourraientnepasêtresuffisantspourfinancerlacroissanceprévue;lesrisquesinhérentsàl’industrietechnologiqueycomprisl’émergencedetechnologiesrévolutionnairessusceptiblesd’affecterlademandepourlesproduitsetservicesdelaSociété;obtenirlesconsentementsnécessaires;l’incertitudecommercialeéconomiqueconcurrentiellepolitiqueetsocialegénérale;lesaccidentslesconflitsdetravailetlespénuriesetautresrisquesliésauxsecteursdelasantéetdelamédecineainsiqued’autresfacteursderisqueabordésdanslaplusrécentenoticeannuelleetanalysedeladirectiondelaSociétédisponiblessurSEDARàl’adressewwwsedarcomBienquelaSociétéaittentéd’identifierlesfacteursimportantssusceptiblesdefairedifférersensiblementlesrésultatsréelsdeceuxcontenusdanslesdéclarationsprospectivesd’autresfacteursmaycauseanyinconsistencybetweenestimatedorprojectedresultsandprojectedresultsThereisnoguaranteethatsuchinformationwillprovetobeaccuratebecauseactualresultsandfutureeventsmaydiffermateriallyfromthoseanticipatedinsuchstatements[FEMININEEngénérallesinformationssurl’avenirpeuventêtreidentifiéesàl’aided’uneterminologieprospectivetelleque«plans»«attendus»ou«nonattendus»«estattendu»«budget»«prévu»«estimations»«prévisions»”al’intentionde””prédit”ou”n’anticipepas”ou”croit”oudesvariationsdecesmotsetexpressionsoudéclarequecertainesactionsévénementsourésultats”peuvent””pourraient””pourraient”ou”serapris””seproduira”ou”seraréalisé”Lesinformationsprospectivessontsoumisesàdesrisquesconnusetinconnusàdesincertitudesetàd’autresfacteursquipourraientfaireensortequelesrésultatsréelsleniveaud’activitélaperformanceoulesréalisationsdelaSociétéselonlecasdiffèrentsensiblementdeceuxexprimésousous-entendusparcesinformationsinformationsprospectivesycomprismaissanss’ylimiter :lesincertitudesliéesàlademanded’uneplateformedetélésantéetdeservicespharmaceutiques ;lesfluxdetrésoreried’exploitationpourraientnepasêtresuffisantspourfinancerlacroissanceprévue ;lesrisquesinhérentsàl’industrietechnologiqueycomprisl’émergencedetechnologiesrévolutionnairessusceptiblesd’affecterlademandepourlesproduitsetservicesdelaSociété ;obtenirlesconsentementsnécessaires ;l’incertitudecommercialeéconomiqueconcurrentiellepolitiqueetsocialegénérale ;lesaccidentslesconflitsdetravailetlespénuriesetautresrisquesliésauxsecteursdelasantéetdelamédecineainsiqued’autresfacteursderisqueabordésdanslaplusrécentenoticeannuelleetanalysedeladirectiondelaSociétédisponiblessurSEDARàl’adressewwwsedarcomBienquelaSociétéaittentéd’identifierlesfacteursimportantssusceptiblesdefairedifférersensiblementlesrésultatsréelsdeceuxcontenusdanslesdéclarationsprospectivesd’autresfacteurspeuvententraîneruneincohérenceentrelesrésultatsetlesrésultatsprojetésestimésouprévusRiennegarantitquecesinformationss’avérerontexactescarlesrésultatsréelsetlesévénementsfuturspeuventdifférersensiblementdeceuxprévusdanscesdéclarationsParconséquentleslecteursnedoiventpastropsefierauxinformationsprospectivesLasociétén’assumeaucuneobligationdemettreàjourlesinformationsprospectivessaufsilesloissurlesvaleursmobilièresapplicablesl’exigent

Share.

Comments are closed.